Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine in Brazilian elderly

Brazilian Journal of Medical and Biological Research

Volumn 38, Issue 2, 2005, Pages 251-260

  Simonsen, V ^a,g   Brandao A P ^b,c   Brandileone, M C C ^a   Yara, T I ^d   Di Fabio, J L ^e   Lopes, M H ^f   Filho, W Jacob ^f  

^a INSTITUTO ADOLFO LUTZ   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FUNDAÇÃO NACIONAL DE SAÚDE   (Brazil)

^d INSTITUTO BUTANTAN   (Brazil)

^e PAN AMERICAN HEALTH ORGANIZATION   (United States)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

^g NONE   (Brazil)

Author keywords

Elderly subjects; Immune response; Pneumococcal polysaccharide vaccine; Streptococcus pneumoniae; Vaccine

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ADULT; AGED; ANALYTIC METHOD; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BRAZIL; CLINICAL PROTOCOL; CONTROLLED STUDY; DELTOID MUSCLE; DOSE RESPONSE; DOSE TIME EFFECT RELATION; ELDERLY CARE; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNOLOGY; FEMALE; FOLLOW UP; GENERAL HOSPITAL; GEOMETRY; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTPATIENT CARE; SEROTYPE; STREPTOCOCCUS INFECTION; UNIVERSITY HOSPITAL; VACCINATION;

PNEUMOCOCCUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 14944356028     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2005000200014     Document Type: Article

References (32)

1. Vlasich C (2001). Pneumococcal infection and vaccination in the elderly. Vaccine, 19: 2233-2237.
2. Mieczkowisk TA & Wilson SA (2002). Adult pneumococcal vaccination: a review of physician and patients. Vaccine, 20: 1383-1392.
3. Fedson DS, Scott JA & Scott G (1999). The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known. Vaccine, 17: S11-S18.
4. Fedson DS (1999). The clinical effectiveness of pneumococcal vaccination: a brief review. Vaccine, 17: S85-S90.
5. Toniolo-Neto J, Weckx LW, Halker E, Lopes CH, de Menezes Succi RC, de Paiva TM, Ishida MA & Forleo-Neto E (1999). Safety of simultaneous pneumococcal and influenza vaccination in elderly patients in Brazil. Drugs and Aging, 15 (Suppl 1): 43-45.
6. Aranda CMSS (1999). Vacinação para o idoso no ano de 1999. Revista CIP - Ações em Saúde, 3: 13-18.
7. Plikaytis BD, Goldblat D, Frasch CE et al. (2000). An analytical model applied to a multicenter pneumococcal enzyme linked immunosorbent assay study. Journal of Clinical Microbiology, 38: 2043-2050.
8. Quataert SA, Kirch CS, Quackenbush LJ, Phipps DC, Strohmeyer S, Cimino CO, Skuse J & Madore DV (1995). Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S. Clinical and Diagnostic Laboratory Immunology, 2: 590-597.
9. Plikaytis BD, Holder PF & Carlone GM (1995). Program ELISA for Windows User's Manual, Version 1.00. Centers for Disease Control and Prevention, Atlanta, GA, USA.
10. Shelley MA, Jacoby H, Riley GJ, Graves BT, Pichichero M & Treanor JJ (1997). Comparison of pneumococcal polysaccharicle and CRM-197 conjugated pneumococcal oligosaccharide vaccines in young and elderly adults. Infection and Immunity, 65: 242-247.
11. Kayhty H, Ahman H, Ronnberg PR, Tillikainen R & Eskola J (1995). Pneumococcal polysaccharicle-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children. Journal of Infectious Diseases, 172: 1273-1278.
12. Sankilampi U, Honkanen PO, Bloigu A, Herva E & Leinonen M (1996). Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly. Journal of Infectious Diseases, 173: 387-393.
13. Coughlin RT, White AC, Anderson CA, Carlone GM, Klein DL & Treanor J (1998). Characterization of pneumococcal specific antibodies in healthy unvaccinated adults. Vaccine, 16: 1761-1767.
14. Brandileone MC, Andrade AL, Di Fabio JL, Guerra ML & Austrian R (2003). Appropriateness of a pneumococcal conjugate vaccine in Brazil: potential impact of age and clinical diagnosis, with emphasis on meningitis. Journal of Infectious Diseases, 187: 1206-1212.
15. Go ES & Ballas ZK (1996). Anti-pneumococcal antibody response in normal subjects: a meta analysis. Journal of Allergy and Clinical Immunology, 98: 205-215.
16. Rubbins JB, Puri AKG, Loch J, Charboneau D, MacDonald R, Opstad N & Janoff EM (1998). Magnitude, duration, quality and function of pneumococcal vaccine responses in elderly adults. Journal of Infectious Diseases, 178: 431-440.
17. Soininen A, van den Dobbelsteen G, Oomen L & Kayhty H (2002). Are the enzyme immunoassays for antibodies to pneumococcal capsular polysaccharicles serotype specific? Clinical and Diagnostic Laboratory Immunology, 7: 468-476.
18. Soininen A, Karpala M, Wahlman SL, Lehtonen H & Kayhty H (2002). Specificities and opsonophagocytic activities of antibodies to pneumococcal capsular polysaccharides in sera of unimmunized young children. Clinical and Diagnostic Laboratory Immunology, 9: 1032-1038.
19. Romero-Steiner S, Libutti D, Pais LB, Dykes J, Anderson P, Whitin JC, Keyserling HL & Carlone GM (1997). Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clinical and Diagnostic Laboratory Immunology, 4: 415-422.
20. Romero-Steiner S, Musher DM, Cetron MS, Pais LB, Groover JE, Fiore AE, Plykaytis BD & Carlone G (1999). Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clinical Infectious Diseases, 29: 281-288.
21. Koskella M (1987). Serum antibodies to pneumococcal C polysaccharide in children: response to acute pneumococcal otites media or to vaccination. Pediatric Infectious Disease, 6: 519-526.
22. Yu X, Sun Y, Frasch C, Conception N & Nahm MH (1999). Pneumococcal capsular polysaccharide preparations may contain non-C polysaccharide contaminants that are immunogenic. Clinical and Diagnostic Laboratory Immunology, 6: 519-524.
23. Soininen A, Pursiainen H, Kilpi T & Kayhty H (2001). Natural development of antibodies to pneumococcal polysaccharicle depends on the serotype: association with pneumococcal carriage and acute otitis media in young children. Journal of Infectious Diseases, 184: 569-575.
24. Wernette CM, Frasch CE, Madore DV et al. (2003). Enzyme-linked immunosorbent assay for quantification of human antibodies to pneumococcal polysaccharides. Clinical and Diagnostic Laboratory Immunology, 10: 514-519.
25. Conception N & Frasch C (2001). Pneumococcal type 22 F polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay. Clinical and Diagnostic Laboratory Immunology, 8: 266-272.
26. Rubbins JB, Alter M, Loch J & Janoff EN (1999). Determination of antibody responses of elderly adults to all 23 capsular polysaccharides after pneumococcal vaccination. Infection and Immunity 67: 5979-5989.
27. Musher DM, Groover JE, Graviss EA & Baughn RE (1996). Lack of association between aging and post vaccination levels of IgG antibody capsular polysaccharides of Streptococcus pneumoniae. Clinical Infectious Diseases, 22: 165-167.
28. Musher DM, Groover JE, Rowland JM, Watson DA, Struewing JB, Baughn RE & Mufson MA (1993). Antibody to capsular polysaccharides of S. pneumoniae: prevalence, persistence and response to revaccination. Clinical Infectious Diseases, 17: 66-73.
29. Sankilampi U, Honkanen PC, Bloigu A & Leinonen M (1997). Persistence of pneumococcal capsular polysaccharide vaccine in the elderly. Journal of Infectious Diseases, 176: 1100-1104.
30. Sorensen RU, Leiva LE, Javier III FC, Sacerdote DM, Bradford N, Butler B, Giangrosso PA & Moore C (1998). Influence of age on the response to S. pneumoniae in patients with recurrent infections and normal immunoglobulin concentrations. Journal of Allergy and Clinical Immunology, 102: 215-221.
31. Conception N & Frasch C (1998). Evaluation of previously assigned antibody concentrations in pneumococcal polysaccharide reference serum 89-SF by the method of cross-standardization. Clinical and Diagnostic Laboratory Immunology, 5: 199-204.
32. Quataert SA, Kirch C, Diakun K & Madore DV (1998). Antibody units assigned to anti-pneumococcal serum lot 89-S. In: Program and Abstracts of the International Symposium on Pneumococci and Pneurnococcal Disease, Helsinger, Denmark. Streptococcus Unit at Statens Serum Institute, Copenhagen, Denmark, 1998: 67 (Abstract P-28).